
    
      This study will also find out whether or not there are certain biological factors that show
      up in patients during their treatment with this drug. This will be able to predict how their
      disease will respond to the therapy (biomarkers), and this will possibly allow anti-cancer
      therapies to be developed in the future to tailor to a patient's needs.
    
  